Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2023

08-03-2023 | Endoscopy | Original Article

The Association Between Low Body-Mass Index and Serious Post-endoscopic Adverse Events

Authors: Netta Glaubach, Dana Ben Hur, Alexander Korytny, Yoni Isenberg, Yousef Laham, Ronit Almog, Irit Chermesh, Roni Weisshof, Haggai Bar-Yoseph

Published in: Digestive Diseases and Sciences | Issue 6/2023

Login to get access

Abstract

Background

Low body mass index (LBMI) was associated with longer colonoscopy procedure time and procedural failure, and commonly considered to be a risk factor for post-endoscopic adverse events, but evidence is lacking.

Aim

We aimed to assess the association between serious adverse events (SAE) and LBMI.

Methods

A single center retrospective cohort of patients with LBMI (BMI ≤ 18.5) undergoing an endoscopic procedure was matched (1:2 ratio) to a comparator group (19 ≤ BMI ≤ 30). Matching was performed according to age, gender, inflammatory bowel disease or malignancy diagnoses, previous abdomino-pelvic surgery, anticoagulation therapy and type of endoscopic procedure. The primary outcome was SAE, defined as bleeding, perforation, aspiration or infection, following the procedure. The attribution between each SAE and the endoscopic procedure was determined. Secondary outcomes included each complication alone and endoscopy-attributed SAEs. Univariate and multivariate analyses were applied.

Results

1986 patients were included (662 in the LBMI group). Baseline characteristics were mostly similar between the groups. The primary outcome occurred in 31/662 (4.7%) patients in the LBMI group and in 41/1324 (3.1%) patients in the comparator group (p = 0.098). Among the secondary outcomes, infections (2.1% vs. 0.8%, p = 0.016) occurred more frequently in the LBMI group. Multivariate analysis revealed an association between SAE and LBMI (OR 1.76, 95% CI 1.07–2.87), male gender, diagnosis of malignancy, high-risk endoscopic procedure, age > 40 years, and ambulatory setting.

Conclusion

Low BMI was associated with higher post-endoscopic serious adverse events. Special attention is required when performing endoscopy in this fragile patient population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Whitlock EP, Lin JS, Liles E et al. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:638–58.CrossRefPubMed Whitlock EP, Lin JS, Liles E et al. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:638–58.CrossRefPubMed
2.
go back to reference Ben-Menachem T, Decker GA, Early DS et al. ASGE Standards of Practice Committee, Adverse events of upper GI endoscopy. Gastrointest Endosc. 2012;76:707–718.CrossRefPubMed Ben-Menachem T, Decker GA, Early DS et al. ASGE Standards of Practice Committee, Adverse events of upper GI endoscopy. Gastrointest Endosc. 2012;76:707–718.CrossRefPubMed
3.
go back to reference Warren JL, Klabunde CN, Mariotto AB et al. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med. 2009;150:849–857.CrossRefPubMed Warren JL, Klabunde CN, Mariotto AB et al. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med. 2009;150:849–857.CrossRefPubMed
4.
go back to reference Kanno A, Yasuda I, Irisawa A et al. Adverse events of endoscopic ultrasound-guided fine-needle aspiration for histologic diagnosis in Japanese tertiary centers: Multicenter retrospective study. Dig Endosc. 2021;33:1146–1157.CrossRefPubMed Kanno A, Yasuda I, Irisawa A et al. Adverse events of endoscopic ultrasound-guided fine-needle aspiration for histologic diagnosis in Japanese tertiary centers: Multicenter retrospective study. Dig Endosc. 2021;33:1146–1157.CrossRefPubMed
5.
go back to reference Szary NM, Al-Kawas FH. Complications of endoscopic retrograde cholangiopancreatography: how to avoid and manage them. Gastroenterol Hepatol 2013;9:496–504. Szary NM, Al-Kawas FH. Complications of endoscopic retrograde cholangiopancreatography: how to avoid and manage them. Gastroenterol Hepatol 2013;9:496–504.
6.
go back to reference Im JP, Cha JM, Kim JW et al. Proton pump inhibitor use before percutaneous endoscopic gastrostomy is associated with adverse outcomes. Gut Liver. 2014;8:248–253.CrossRefPubMed Im JP, Cha JM, Kim JW et al. Proton pump inhibitor use before percutaneous endoscopic gastrostomy is associated with adverse outcomes. Gut Liver. 2014;8:248–253.CrossRefPubMed
7.
go back to reference Kothari ST, Huang RJ, Shaukat A et al. ASGE review of adverse events in colonoscopy. Gastrointest Endosc. 2019;90:863–876.CrossRefPubMed Kothari ST, Huang RJ, Shaukat A et al. ASGE review of adverse events in colonoscopy. Gastrointest Endosc. 2019;90:863–876.CrossRefPubMed
8.
go back to reference Sharma VK, Nguyen CC, Crowell MD et al. A national study of cardiopulmonary unplanned events after GI endoscopy. Gastrointest Endosc. 2007;66:27–34.CrossRefPubMed Sharma VK, Nguyen CC, Crowell MD et al. A national study of cardiopulmonary unplanned events after GI endoscopy. Gastrointest Endosc. 2007;66:27–34.CrossRefPubMed
9.
10.
11.
go back to reference Akere A, Otegbayo JA. Complete colonoscopy: impact of patients’ demographics and anthropometry on caecal intubation time. BMJ Open Gastroenterol. 2016;3:e000076.CrossRefPubMedPubMedCentral Akere A, Otegbayo JA. Complete colonoscopy: impact of patients’ demographics and anthropometry on caecal intubation time. BMJ Open Gastroenterol. 2016;3:e000076.CrossRefPubMedPubMedCentral
12.
go back to reference Jaruvongvanich V, Sempokuya T, Laoveeravat P et al. Risk factors associated with longer cecal intubation time: a systematic review and meta-analysis. Int J Colorectal Dis. 2018;33:359–365.CrossRefPubMed Jaruvongvanich V, Sempokuya T, Laoveeravat P et al. Risk factors associated with longer cecal intubation time: a systematic review and meta-analysis. Int J Colorectal Dis. 2018;33:359–365.CrossRefPubMed
13.
go back to reference Krishnan P, Sofi AA, Dempsey R et al. Body mass index predicts cecal insertion time: the higher, the better. Dig Endosc. 2012;24:439–442.CrossRefPubMed Krishnan P, Sofi AA, Dempsey R et al. Body mass index predicts cecal insertion time: the higher, the better. Dig Endosc. 2012;24:439–442.CrossRefPubMed
14.
go back to reference Arcovedo R, Larsen C, Reyes HS. Patient factors associated with a faster insertion of the colonoscope. Surg Endosc. 2007;21:885–888.CrossRefPubMed Arcovedo R, Larsen C, Reyes HS. Patient factors associated with a faster insertion of the colonoscope. Surg Endosc. 2007;21:885–888.CrossRefPubMed
15.
go back to reference Goksoy B, Kiyak M, Karadag M et al. Factors affecting cecal intubation time in colonoscopy: impact of obesity. Cureus. 2021;13:e15356.PubMedPubMedCentral Goksoy B, Kiyak M, Karadag M et al. Factors affecting cecal intubation time in colonoscopy: impact of obesity. Cureus. 2021;13:e15356.PubMedPubMedCentral
16.
go back to reference Qureshi A, BiBi S, Madhotra R. Body mass index & low CIR in colonoscopy! Gastroenterol Hepatol Bed Bench. 2018;11:125–130.PubMedPubMedCentral Qureshi A, BiBi S, Madhotra R. Body mass index & low CIR in colonoscopy! Gastroenterol Hepatol Bed Bench. 2018;11:125–130.PubMedPubMedCentral
17.
go back to reference Van der Maarel-Wierink CD, Vanobbergen JN, Bronkhorst EM et al. Risk factors for aspiration pneumonia in frail older people: a systematic literature review. J Am Med Dir Assoc. 2011;12:344–354.CrossRefPubMed Van der Maarel-Wierink CD, Vanobbergen JN, Bronkhorst EM et al. Risk factors for aspiration pneumonia in frail older people: a systematic literature review. J Am Med Dir Assoc. 2011;12:344–354.CrossRefPubMed
18.
go back to reference Veitch AM, Radaelli F, Alikhan R et al. Endoscopy in patients on antiplatelet or anticoagulation therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update. Gut. 2021;70:1611–1628.CrossRefPubMed Veitch AM, Radaelli F, Alikhan R et al. Endoscopy in patients on antiplatelet or anticoagulation therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update. Gut. 2021;70:1611–1628.CrossRefPubMed
19.
go back to reference Gemma M, Pennoni F, Tritto R et al. Risk of adverse events in gastrointestinal endoscopy: zero-inflated Poisson regression mixture model for count data and multinomial logit model for the type of event. PLoS One. 2021;16:e0253515.CrossRefPubMedPubMedCentral Gemma M, Pennoni F, Tritto R et al. Risk of adverse events in gastrointestinal endoscopy: zero-inflated Poisson regression mixture model for count data and multinomial logit model for the type of event. PLoS One. 2021;16:e0253515.CrossRefPubMedPubMedCentral
21.
go back to reference Ho DE, Imai K, King G et al. MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw 2001;42:1–28. Ho DE, Imai K, King G et al. MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw 2001;42:1–28.
22.
go back to reference Anderson JC, Messina CR, Cohn W et al. Factors predictive of difficult colonoscopy. Gastrointest Endosc. 2001;54:558–562.CrossRefPubMed Anderson JC, Messina CR, Cohn W et al. Factors predictive of difficult colonoscopy. Gastrointest Endosc. 2001;54:558–562.CrossRefPubMed
23.
go back to reference Dizdar OS, Baspınar O, Kocer D et al. Nutritional risk, micronutrient status and clinical outcomes: a prospective observational study in an infectious disease clinic. Nutrients. 2016;8:124.CrossRefPubMedPubMedCentral Dizdar OS, Baspınar O, Kocer D et al. Nutritional risk, micronutrient status and clinical outcomes: a prospective observational study in an infectious disease clinic. Nutrients. 2016;8:124.CrossRefPubMedPubMedCentral
24.
go back to reference Chen B, Liu W, Chen Y et al. Effect of poor nutritional status and comorbidities on the occurrence and outcome of pneumonia in elderly adults. Front Med (Lausanne). 2021;8:719530.CrossRefPubMedPubMedCentral Chen B, Liu W, Chen Y et al. Effect of poor nutritional status and comorbidities on the occurrence and outcome of pneumonia in elderly adults. Front Med (Lausanne). 2021;8:719530.CrossRefPubMedPubMedCentral
25.
go back to reference Isenberg Y, Zamstein N, Horesh N et al. Risk factors for bacteremia after endoscopic procedures in hospitalized patients with a focus on neutropenia. J Clin Gastroenterol. 2022;56:e58–e63.CrossRefPubMed Isenberg Y, Zamstein N, Horesh N et al. Risk factors for bacteremia after endoscopic procedures in hospitalized patients with a focus on neutropenia. J Clin Gastroenterol. 2022;56:e58–e63.CrossRefPubMed
26.
go back to reference Gao Q, Cheng Y, Li Z et al. Association between nutritional risk screening score and prognosis of patients with sepsis. Infect Drug Resist. 2021;14:3817–3825.CrossRefPubMedPubMedCentral Gao Q, Cheng Y, Li Z et al. Association between nutritional risk screening score and prognosis of patients with sepsis. Infect Drug Resist. 2021;14:3817–3825.CrossRefPubMedPubMedCentral
Metadata
Title
The Association Between Low Body-Mass Index and Serious Post-endoscopic Adverse Events
Authors
Netta Glaubach
Dana Ben Hur
Alexander Korytny
Yoni Isenberg
Yousef Laham
Ronit Almog
Irit Chermesh
Roni Weisshof
Haggai Bar-Yoseph
Publication date
08-03-2023
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2023
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-023-07882-9

Other articles of this Issue 6/2023

Digestive Diseases and Sciences 6/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine